• NAGEN > Navarrabiomed leads the Navarre Genomic Medicine Strategy (NAGEN) of the regional public health system. Thanks to the support of the Government of Navarre, the center has promoted the development of six strategic projects to implement genomic analysis technology and the use of the information obtained for accurate diagnosis and treatment. (read more)
• ISOLDA > The goal of the EU-funded ISOLDA Project is to develop novel vaccines against viral diseases for older age by promoting virus-specific T cell responses targeting T cell immunosenescence and inflamm-ageing. Together with the State Agency for the Higher Council for Scientific Research (CSIC, Consejo Superior de Investigaciones Científicas), Navarrabiomed represents the spanish research for the ISOLDA Project. (read more)
  • IMPaCT > Navarrabiomed leads in Navarra the Precision Medicine Infrastructure associated with Science and Technology (IMPaCT) coordinated by Carlos III Health Institute. It is considered the first step of the new Spanish Strategy Personalized Medicine and it is organized in three programs: Predictive Medicine, Data Science and Genomic Medicine.

It will allow progress in the implementation of a new way of doing medicine, linked to scientific knowledge and the ability to exploit all available information to increase the quality and efficiency of the health system. (read more)

• PROCURE4HEALTH > Navarrabiomed takes part in the Procure4Health Project, which is a growing community of European Health organisations interested in procurement of innovation. The partners actively promote innovation procurement through knowledge sharing and capacity building; networking and matchmaking; identification of common needs and the launch of joint actions to address them as well as influencing policy on procurement of innovation. (read more)